Thomas Powles, MBBS, MRCP, MD
Thomas Powles, MBBS, MRCP, MD, is a Professor of Genitourinary Oncology and Director at Barts Cancer Centre at St. Bartholomew’s Hospital in London, UK, as well as Lead for Solid Tumour Research. Dr. Powles also serves as co-host of The Uromigos podcast.
Articles by Thomas Powles, MBBS, MRCP, MD
Dr. Powles offers his thoughts on the latest OS data from EV-302 for patient subgroups and immune-related toxicity.
Dr. Powles gives his unique feedback on what to make of KEYNOTE-564 and how aRCC frontline options should be compared.
The panel shares predictions for the future of bladder cancer.
The panel discusses other exciting treatment advances in bladder cancer.
How the potential shift of new therapies to the frontline setting will impact subsequent treatment decisions.
The panel discussed optimal treatment cycles for enfortumab vedotin/pembrolizumab.
The panel shared their thoughts on the EV-302 study.
The panel kicked off with conversations about data released at ESMO, including EV-302 and CheckMate 901.
Drs. Powles and Nizam discuss her strategy of intensifying treatment upfront in oligometastatic urothelial carcinoma.
Drs. Powles, Tawagi, and Berg highlight attempts to define 2L SOC options, as well IO rechallenging in bladder cancer.
Drs. Powles and Koshkin break down the Q-TWiST analysis conducted on the JAVELIN Bladder 100 study for advanced UC.
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.